2019-2023 In Vitro Diagnostics Market: Strategic Implications of Emerging Reimbursement, Technological and Market Trends

- How will the future reimbursement changes affect individual market segments?

- Will the industry consolidate, decentralize, or undergo a bimodal transformation?

- What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?

- How will the future technological advances affect the major market segments?

- Which companies will enter the market and which will not survive?

These and other key strategic issues facing decision-makers are explored in this thought-provoking and multi-faceted portrait of the future U.S. in vitro diagnostics market.

This invaluable strategic planning resource is designed to help corporate, marketing and R&D executives develop effective business plans that best accommodate uncertainties ahead. The report evaluates emerging markets and technologies that may present unexpected threats or offer opportunities; identifies key strategic decisions that will have to be made in the future; and enhances corporate ability to develop realistic contingency plans.

The report presents strategic overview of the U.S. in vitro diagnostics market, including major regulatory, economic, demographic and social trends with potentially significant impact; as well as five- and ten-year test volume and sales forecasts for major testing locations (hospitals, commercial labs, physician offices, blood centers, POC sites, and others) and laboratory disciplines (blood banking, clinical chemistry, immunodiagnostics, coagulation, hematology, flow cytometry, histology, cytology, microbiology, serology, urinalysis and others).

I. Executive Summary
2. Conclusions and Recommendations
3. Business Environment
a. Health Care Expenditures
b. Cost-Consciousness
c. Reimbursement
d. Industry Consolidation
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Aging Population
- More Chronic Illnesses
- Higher Incidence of Disease
- Greater Susceptibility to Iatrogenesis
- More Cases with Multiple Illnesses
4. Outlook for the In Vitro Diagnostics Market
a. Government Regulations
b. FDA Reform
c. Hospitals
d. Commercial Laboratories
e. Physician Offices
f. Point-of-Care Testing
g. Personal Testing
h. Other Testing Locations
5. Strategic Implications
a. Testing Patterns
- Test Utilization
- Pre-Admission Testing
- Inpatient Testing
- Outpatient Testing
6. Market Segments
a. Clinical Chemistry and Immunodiagnostics
- Introduction
- Future Situation
b. Microbiology and Serology
- Introduction
- Future Situation
c. Hematology and Flow Cytometry
- Introduction
- Future Situation
d. Blood Banking
- Introduction
- Future Situation
e. Histology and Cytology
- Introduction
- Future Situation
f. Coagulation
- Introduction
- Future Situation
g. Urinalysis
- Introduction
- Future Situation
7. Technologies
a. Molecular Diagnostics
- Introduction
- Future Situation
b. Monoclonal Antibodies
- Introduction
- Future Situation
c. Solid Phase Chemistry
- Introduction
- Future Situation
d. Biosensors and Biochips
- Introduction
- Future Situation
e. Automation and Robotics
- Introduction
- Future Situation
f. IT
- Introduction
- Future Situation
8. The New Marketplace
a. Purchasing Influences
b. Marketing Strategies
c. Joint Venture, Merger, and Licensing Activity
d. Import-Export
e. Potential Market Entrants
f. Who May Not Survive?

List Of Tables

Executive Summary Table: Growth Areas in Clinical Laboratory Testing
Table-1: Estimated U.S. Health Care Expenditures By Type
Table-2: Health Plan Enrollment Distribution
Table-3: Selected Hospital Statistics
Table-4: Total Population And Physician Demographics
Table-5: Test Volume By Location
Table-6: Test Distribution By Location
Table-7: Market Size By Location
Table-8: Typical Pre-Admission Tests
Table-9: Test Volume By Laboratory Discipline
Table-10: Market Size By Laboratory Discipline

Global Yersinia Diagnostics Market, 2019-2023: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--US, Europe, Japan--Hospitals, Commercial and Public Health Labs, POC Locations

The report presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Yersinia definition,

USD 4350 View Report

Global West Nile Diagnostics Market, 2019-2023: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--US, Europe, Japan--Hospitals, Commercial and Public Health Labs, POC Locations

This report presents test volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for West Nile tests

USD 950 View Report

Global Lungs in Vitro Market Report 2019 - Market Size, Share, Price, Trend and Forecast

The global market size of Lungs in Vitro is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the

USD 4000 View Report

Global IVD (In Vitro Diagnostic) Testing Market Report 2019 - Market Size, Share, Price, Trend and Forecast

The global market size of IVD (In Vitro Diagnostic) Testing is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million

USD 4000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available